E Fund Management Co., Ltd.

Position in COGT — Cogent Biosciences, Inc.

CIK 1842296 GUANGZHOU, F4

Position in COGT

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$500,313

-$119,529 QoQ

Shares Held

12,928

-19.7% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#209

of 321 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

E Fund Management Co., Ltd. holds $66,079,043 across 109 Biotechnology names. COGT ranks #24 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,455	$5,690,042
2	ERAS	Erasca, Inc.	265,381	$4,861,779
3	CELC	Celcuity Inc.	45,895	$4,801,534
4	EYPT	EyePoint, Inc.	330,774	$4,730,068
5	AVBP	ArriVent BioPharma, Inc.	109,328	$3,798,054
6	REGN	Regeneron Pharmaceuticals, Inc.	5,158	$3,216,219
7	LEGN	Legend Biotech Corp	109,327	$3,157,363
8	ALNY	Alnylam Pharmaceuticals, Inc.	6,073	$1,828,155

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$500,313	12,928	-19.7%	Shares	Defined	2026-08-11
2026-03-31	$619,842	16,104	+57.8%	Shares	Defined	2026-04-13
2025-06-30	$73,271	10,205	-34.9%	Shares	Sole	2025-08-15
2025-03-31	$93,863	15,670	+37.7%	Shares	Sole	2025-05-13
2024-12-31	$88,764	11,380	+1.9%	Shares	Sole	2025-02-07
2024-06-30	$94,188	11,173	-66.5%	Shares	Sole	2024-08-12
2024-03-31	$223,829	33,308	+116.1%	Shares	Sole	2024-05-13
2023-12-31	$90,616	15,411	+39.0%	Shares	Sole	2024-02-07
2023-06-30	$131,281	11,088	-19.4%	Shares	Sole	2023-08-11
2023-03-31	$148,351	13,749	-19.0%	Shares	Sole	2023-05-11
2022-12-31	$196,231	16,975	+18.0%	Shares	Sole	2023-02-14
2022-09-30	$214,698	14,390	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.